2005-2010年我院住院药房麻醉药品利用分析及干预措施  

Analysis and interventions of narcotic drugs in inpatient pharmacy from 2005 to 2010

作　　者：陈春玲[1] 朱华[1] 许建国[1] 邵建屛 李贤文[1] 

机构地区：[1]江苏省苏北人民医院,江苏扬州225001

出　　处：《实用药物与临床》2012年第4期226-228,共3页Practical Pharmacy and Clinical Remedies

摘　　要：目的分析我院住院药房麻醉药品的应用情况,评价其合理性。方法对我院2005-2010年住院药房麻醉药品的销售金额、用量、用药频度(DDDs)进行统计、分析。结果我院麻醉药品共涉及12个品种、4种剂型,销售金额、用量基本呈逐年递增趋势。DDDs居首位的是芬太尼注射液和4.2 mg芬太尼透皮贴剂。芬太尼制剂、吗啡制剂增幅较大,哌替啶注射液用量逐年递减。结论通过采取有效的干预措施,我院麻醉药品用药结构趋于合理,用药基本合理。Objective To investigate the application of narcotic drugs in inpatient pharmacy of our hospital,and evaluate the rationality.Methods The narcotic drugs in inpatient pharmacy of our hospital were analyzed statistically in respect of consumption sum,consumption quantity and DDDs from 2005 to 2010.Results There were 12 kinds of narcotic drugs including 4 dosage forms.Consumption sum and quantity of narcotic drugs increased year by year.Fentanyl injection and fentanyl transdermal patch took the lead in terms of DDDs.The consumption amount of morphines and fentanyl showed an obvious increasing trend,while that of pethidine injection decreased to a large extent.Conclusion The application structure of narcotic drugs has become reasonable gradually,and the narcotic drugs use is rational basically through effect interventions.

关 键 词：麻醉药品 用药分析 用药频度 干预措施 

分 类 号：R96[医药卫生—药理学]